drugset / Trial / NCT00150241
A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to measure the safety and efficacy of three doses of varenicline for smoking cessation.
Timeline
- Start
- 2000-02
- Primary completion
- —
- Completion
- 2002-01
Publications
- Hajizadeh A, Howes S, Theodoulou A, Klemperer E, Hartmann-Boyce J, Livingstone-Banks J, Lindson N. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2023 May 24;5(5):CD000031. doi: 10.1002/14651858.CD000031.pub6.
- Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varenicline | Small molecule | 0.3 mg | — |
| Subject | Varenicline | Small molecule | 1 mg | — |
Indications
No indication recorded.